Hyperglycemic Crises in Adult Patients With Diabetes
Open accessThe DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
PRECIPITATING FACTORS -The most common precipitating factor in the development of DKA and HHS is infection (1,4,10).Other precipitating factors include discontinuation of or inadequate insulin therapy, pancreatitis, myocardial infarction, cerebrovascular accident, and
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, DKA can also occur in persons with T2D.28–31”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [28]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For people with type 2 diabetes, other strategies to assist them with insulin dosing can improve A1C with minimal hypoglycemia (133,134).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [134]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Standards for Diabetes Self-Management Education
Funnell, M. M., Brown, T. L., Childs, B. P., Haas, L. B., Hosey, G. M., Jensen, B., Maryniuk, M., Peyrot, M., Piette, J. D., Reader, D., et al. (2009) · Diabetes Care · doi:10.2337/dc09-s087 · Cited by 1,350
Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007074420772 · Cited by 803
Risk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis
Glaser, N., Barnett, P., McCaslin, I., Nelson, D., Trainor, J., Louie, J., Kaufman, F., Quayle, K., Roback, M., Malley, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440404 · Cited by 779
International Textbook of Diabetes Mellitus
(2004) · Wiley eBooks · doi:10.1002/0470862092 · Cited by 725
Management of Hyperglycemic Crises in Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., & Wall, B. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.131 · Cited by 710
Self-citationWeissberg-Benchell, J., Antisdel-Lomaglio, J., & Seshadri, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1079 · Cited by 551
Risk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis
(2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442014 · Cited by 533
Hyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationStentz, F. B., Umpierrez, G. E., Cuervo, R., & Kitabchi, A. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2079 · Cited by 497 · cited 1×
“Increasing evidence indicates that the hyperglycemia in patients with hyperglycemic crises is associated with a severe inflammatory state characterized by an elevation of proinflammatory cytokines (tumor necrosis factor-$ and interleukin-#, -6, and -8), C-reactive protein, reactive oxygen species, and lipid peroxidati…”
BackgroundSelf-citationNational Standards for Diabetes Self-Management Education
Funnell, M. M., Brown, T. L., Childs, B. P., Haas, L. B., Hosey, G. M., Jensen, B., Maryniuk, M., Peyrot, M., Piette, J. D., Reader, D., et al. (2008) · Diabetes Care · doi:10.2337/dc08-s097 · Cited by 497
Research works printed but not linked: 3
- 37. Brownlee M, Ed. New York, Garland ATPM Press, 1981, p. 95- 149
- 52. Soveid M, Ranjbar-Omrani G. Ketoacido- sis as the primary manifestation of acro- megaly. Arch Iranian Med 2005;8:326 - 328
- 55. Bratusch-Marrain PR, Komajati M, Waldhausal W. The effect of hyperos- molarity on glucose metabolism. Pract Cardiol 1985;11:153-163
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“For further information on management of DKA or hyperglycemic nonketotic hyperosmolar state, refer to the ADA statement on hyperglycemic crises (288).”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“For further information on management of DKA or hyperglycemic nonketotic hyperosmolar state, refer to the ADA statement on hyperglycemic crises (222).”
BackgroundStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Self-citationType 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Chiang, J. L., Kirkman, M. S., Laffel, L. M. B., Peters, A. L., & Authors, O. B. O. T. T. 1. D. S. (2014) · Diabetes Care · doi:10.2337/dc14-1140 · Cited by 965
Peters, A. L., Buschur, E. O., Buse, J. B., Cohan, P., Diner, J. C., & Hirsch, I. B. (2015) · Diabetes Care · doi:10.2337/dc15-0843 · Cited by 849
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino, T., Alexander, C. M., Amiel, S. A., Arreaza-Rubin, G., Beck, R. W., Bergenstal, R. M., Buckingham, B. A., Carroll, J., Ceriello, A., Chow, E., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00319-9 · Cited by 831
Self-citation6. Glycemic Targets: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s006 · Cited by 762
Health and environmental effects of persistent organic pollutants
Alharbi, O. M. L., Basheer, A. A., Khattab, R. A., & Ali, I. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.05.029 · Cited by 752
6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744
6. Glycemic Targets: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s006 · Cited by 684
6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s006 · Cited by 655
“For further information on the management of diabetic ketoacidosis and the nonketotic hyperglycemic hyperosmolar state, please refer to the ADA consensus report “Hyperglycemic Crises in Adult Patients With Diabetes” (60).”
BackgroundHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Self-citationDiabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Self-citationHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Self-citationEndocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Chang, L.-S., Barroso-Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., & Min, L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00006 · Cited by 532
Japanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationBetaine in Inflammation: Mechanistic Aspects and Applications
Zhao, G., He, F., Wu, C., Li, P., Li, N., Deng, J., Zhu, G., Ren, W., & Peng, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01070 · Cited by 476
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
“3 and a bicarbonate concentration of >18 mmol/l, with low concentrations of urinary or serum ketones and an osmolality of >320 mOsmol/l (reF.(8)).”
BackgroundSelf-citationGlaser, N., Fritsch, M., Priyambada, L., Rewers, A., Cherubini, V., Estrada, S., Wolfsdorf, J. I., & Codner, E. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13406 · Cited by 390
16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s016 · Cited by 440
Diabetes mellitus and electrolyte disorders
Liamis, G. (2014) · World Journal of Clinical Cases · doi:10.12998/wjcc.v2.i10.488 · Cited by 399
Effects of sotagliflozin added to insulin in patients with type 1 diabetes
Garg, S. K., Henry, R. R., Banks, P., Buse, J. B., Davies, M. J., Fulcher, G. R., Pozzilli, P., Gesty-Palmer, D., Lapuerta, P., Simó, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708337 · Cited by 417
Ahmed, S., Sulaiman, S. A., Baig, A. A., Ibrahim, M., Liaqat, S., Fatima, S., Jabeen, S., Shamim, N., & Othman, N. H. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8367846 · Cited by 352
Agiostratidou, G., Anhalt, H., Ball, D., Blonde, L., Gourgari, E., Harriman, K. N., Kowalski, A. J., Madden, P., McAuliffe-Fogarty, A. H., McElwee-Malloy, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1624 · Cited by 397
Glucose Sensing in Supramolecular Chemistry
Sun, X., & James, T. D. (2015) · Chemical Reviews · doi:10.1021/cr500562m · Cited by 386
Pasquel, F. J., & Umpierrez, G. E. (2014) · Diabetes Care · doi:10.2337/dc14-0984 · Cited by 345
Self-citationEpidemiological Perspectives of Diabetes
Tao, Z., Shi, A., & Zhao, J. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-015-0598-4 · Cited by 330
Handelsman, Y., Henry, R. R., Bloomgarden, Z. T., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Ferrannini, E., Fonseca, V. A., Garber, A. J., Grunberger, G., et al. (2016) · Endocrine Practice · doi:10.4158/ep161292.ps · Cited by 358
Self-citationBenoit, S. R., Zhang, Y., Geiss, L. S., Gregg, E. W., & Albright, A. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a3 · Cited by 334
Japanese Clinical Practice Guideline for Diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13306 · Cited by 341
Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis
Savage, M. W., Dhatariya, K. K., Kilvert, A., Rayman, G., Rees, J. A. E., Courtney, C. H., Hilton, L., Dyer, P. H., Hamersley, M. S., & Societies, F. T. J. B. D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03246.x · Cited by 338
Mathieu, C., Zinman, B., Hemmingsson, J. U., Woo, V., Colman, P., Christiansen, E., Linder, M., Bode, B., & for the ADJUNCT ONE Investigators (2016) · Diabetes Care · doi:10.2337/dc16-0691 · Cited by 347
The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management
Nyenwe, E. A., & Kitabchi, A. E. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.007 · Cited by 309
Self-citationManagement of diabetes and hyperglycaemia in the hospital
Pasquel, F. J., Lansang, M. C., Dhatariya, K., & Umpierrez, G. E. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30381-8 · Cited by 329
Self-citationManagement of Hyperglycemic Crises
Fayfman, M., Pasquel, F. J., & Umpierrez, G. E. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.12.011 · Cited by 278
Self-citationJapanese Clinical Practice Guideline for Diabetes 2016
Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E. (2018) · Diabetology International · doi:10.1007/s13340-018-0345-3 · Cited by 319
Dandona, P., Mathieu, C., Phillip, M., Hansen, L., Griffen, S. C., Tschöpe, D., Thorén, F., Xu, J., Langkilde, A. M., Proietto, J., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30308-x · Cited by 293
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s015 · Cited by 265
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s009 · Cited by 271
Hyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278
Self-citationFarsani, S. F., Brodovicz, K., Soleymanlou, N., Marquard, J., Wissinger, E., & Maiese, B. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016587 · Cited by 251
Hyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G., Miles, J., & Fisher, J. (2009) · Diabetes Care · doi:10.2337/dc09-1563 · Cited by 273
Self-citationElectrolyte and Acid–Base Disturbances in Patients with Diabetes Mellitus
Palmer, B. F., & Clegg, D. J. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1503102 · Cited by 251
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s015 · Cited by 216
Synthetic beta cells for fusion-mediated dynamic insulin secretion
Chen, Z., Wang, J., Sun, W., Archibong, E., Kahkoska, A. R., Zhang, X., Lu, Y., Ligler, F. S., Buse, J. B., & Gu, Z. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2511 · Cited by 248
Mathieu, C., Dandona, P., Gillard, P., Senior, P., Hasslacher, C., Araki, E., Lind, M., Bain, S. C., Jabbour, S., Arya, N., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0623 · Cited by 252
“3, decreased serum bicarbonate levels (#18 mEq/L), and symptoms/ signs, as listed by the ADA consensus statement on diagnosis of DKA (22).”
Background16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s016 · Cited by 221
Dandona, P., Mathieu, C., Phillip, M., Hansen, L., Tschöpe, D., Thorén, F., Xu, J., Langkilde, A. M., DEPICT-1 Investigators, Proietto, J., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1087 · Cited by 243
“3 and/or decreased serum bicarbonate levels (#18 mEq/L), and symptoms/signs as listed by the ADA consensus statement on the diagnosis of DKA (11).”
BackgroundKarslioglu French, E., Donihi, A. C., & Korytkowski, M. T. (2019) · BMJ · doi:10.1136/bmj.l1114 · Cited by 200
Management of adult diabetic ketoacidosis
Gosmanov, A. R., Gosmanova, E., & Dillard-Cannon, E. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s50516 · Cited by 223
“1 U/kg bolus of insulin can be given once more while continuing insulin infusion.(3) Of clinical significance is the phenomenon of hyperglycemiainduced insulin resistance; with reduction of glycemia, there can be a nonlinear decrease in insulin requirements.”
BackgroundInfluentialAmerican Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s008 · Cited by 215
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Galindo, R. J., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s016 · Cited by 167
Dhatariya, K. K., & Care, T. J. B. D. S. F. I. (2022) · Diabetic Medicine · doi:10.1111/dme.14788 · Cited by 186
Sodium Bicarbonate Therapy in Patients with Metabolic Acidosis
Adeva-Andany, M. M., Fernández-Fernández, C., Mouriño-Bayolo, D., Castro-Quintela, E., & Domínguez-Montero, A. (2014) · The Scientific World Journal · doi:10.1155/2014/627673 · Cited by 188
Recurrent Diabetic Ketoacidosis in Inner-City Minority Patients
Randall, L., Begovic, J., Hudson, M., Smiley, D., Peng, L., Pitre, N., Umpierrez, D., & Umpierrez, G. (2011) · Diabetes Care · doi:10.2337/dc11-0701 · Cited by 207
Self-citationDesai, D., Mehta, D., Mathias, P., Menon, G., & Schubart, U. K. (2018) · Diabetes Care · doi:10.2337/dc17-1379 · Cited by 206
Kitabchi, A. E., & Nyenwe, E. A. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.006 · Cited by 206
Self-citationAmerican Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s009 · Cited by 205
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s015 · Cited by 197
Hyperglycaemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06183-8 · Cited by 225
Self-citationFonseca, V. A., Grunberger, G., Anhalt, H., Bailey, T. S., Blevins, T., Garg, S. K., Handelsman, Y., Hirsch, I. B., Orzeck, E. A., Roberts, V. L., et al. (2016) · Endocrine Practice · doi:10.4158/ep161392.cs · Cited by 195
“is $218 billion per year (43); hospitalizations for hypoglycemic and hyperglycemic crises may account for up to $5 billion, based on an estimated cost of approximately $17,500 per hospitalization (44-47).”
BackgroundImmune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis
Akturk, H. K., Kahramangil, D., Sarwal, A., Hoffecker, L., Murad, M. H., & Michels, A. W. (2019) · Diabetic Medicine · doi:10.1111/dme.14050 · Cited by 188
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Madhu, S., Chawla, R., Makkar, B., Ghosh, S., Saboo, B., & Kalra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_225_20 · Cited by 167
14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s014 · Cited by 178
Japanese Clinical Practice Guideline for Diabetes 2016
Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12810 · Cited by 181
A Paper-Based “Pop-up” Electrochemical Device for Analysis of Beta-Hydroxybutyrate
Wang, C.-C., Hennek, J. W., Ainla, A., Kumar, A. A., Lan, W.-J., Im, J., Smith, B. S., Zhao, M., & Whitesides, G. M. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b00568 · Cited by 180
Mahler, S. A., Conrad, S. A., Wang, H., & Arnold, T. C. (2011) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2010.02.004 · Cited by 183
Euglycemic diabetic ketoacidosis: A missed diagnosis
Nasa, P., Chaudhary, S., Shrivastava, P. K., & Singh, A. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i5.514 · Cited by 164
Zhong, V. W., Juhaeri, J., & Mayer-Davis, E. J. (2018) · Diabetes Care · doi:10.2337/dc17-1583 · Cited by 177
Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.
Reichman, T. W., Markmann, J. F., Odorico, J., Witkowski, P., Fung, J. J., Wijkstrom, M., Kandeel, F., de Koning, E. J. P., Peters, A. L., Mathieu, C., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2506549 · Cited by 177
Endocrine side effects of cancer immunotherapy
Cukier, P., Santini, F. C., Scaranti, M., & Hoff, A. O. (2017) · Endocrine-Related Cancer · doi:10.1530/erc-17-0358 · Cited by 177
Euglycemic diabetic ketoacidosis
Barski, L., Eshkoli, T., Brandstaetter, E., & Jotkowitz, A. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.03.014 · Cited by 176
Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis
Chua, H., Venkatesh, B., Stachowski, E., Schneider, A. G., Perkins, K., Ladanyi, S., Krüger, P., & Bellomo, R. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.01.007 · Cited by 175
Dhatariya, K. K., & Vellanki, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0857-4 · Cited by 162
Roussel, R., Riveline, J.-P., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2021) · Diabetes Care · doi:10.2337/dc20-1690 · Cited by 173
Risk of death following admission to a UK hospital with diabetic ketoacidosis
Gibb, F. W., Teoh, W. L., Graham, J., & Lockman, K. A. (2016) · Diabetologia · doi:10.1007/s00125-016-4034-0 · Cited by 170
“Recent estimates of inpatient DKAmortality have varied between <1% [2] and up to 1.”
BackgroundResultEllagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy
Ahad, A., Ganai, A. A., Mujeeb, M., & Siddiqui, W. A. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.05.011 · Cited by 159
Pasquel, F. J., Tsegka, K., Wang, H., Cardona, S., Galindo, R. J., Fayfman, M., Davis, G., Vellanki, P., Migdal, A., Gujral, U., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1168 · Cited by 161
“We then confirmed the diagnosis according to admission laboratory values with the presence of metabolic acidosis and/ or hyperosmolality (we used estimations of osmolality as commonly used in clinical practice) (9).”
BackgroundMethodInfluentialSelf-citationDiabetic keratopathy: Insights and challenges
Priyadarsini, S., Whelchel, A. E., Nicholas, S. E., Sharif, R., Riaz, K. M., & Karamichos, D. (2020) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.02.005 · Cited by 164
Evidence-based practice guideline for the treatment for diabetes in Japan 2013
Tajima, N., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Fujimoto, K., Sakamoto, M., & Haneda, M. (2015) · Diabetology International · doi:10.1007/s13340-015-0206-2 · Cited by 154
Euglycemic diabetic ketoacidosis: etiologies, evaluation, and management
Long, B., Lentz, S., Koyfman, A., & Gottlieb, M. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.02.015 · Cited by 150
Self, W. H., Evans, C. S., Jenkins, C. A., Brown, R. M., Casey, J. D., Collins, S. P., Coston, T. D., Felbinger, M., Flemmons, L. N., Hellervik, S. M., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.24596 · Cited by 170
Triple threat: how diabetes results in worsened bacterial infections
Darwitz, B. P., Genito, C. J., & Thurlow, L. R. (2024) · Infection and Immunity · doi:10.1128/iai.00509-23 · Cited by 164
Ehrmann, D., Kulzer, B., Roos, T., Haak, T., Al-Khatib, M., & Hermanns, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30042-5 · Cited by 141
Evidence-based management of hyperglycemic emergencies in diabetes mellitus
Nyenwe, E. A., & Kitabchi, A. E. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.012 · Cited by 157
Self-citationEuglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma
Rawla, P., Vellipuram, A. R., Bandaru, S. S., & Pradeep Raj, J. (2017) · Endocrinology, Diabetes & Metabolism Case Reports · doi:10.1530/edm-17-0081 · Cited by 139
“On the other hand, there will be lipolysis and fatty acid production, which finally leads to excessive ketone body production (3).”
BackgroundSingh, H., Singh, J. V., Bhagat, K., Gulati, H. K., Sanduja, M., Kumar, N., Kinarivala, N., & Sharma, S. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.06.033 · Cited by 146
Glucose Sensor using Liquid-Crystal Droplets Made by Microfluidics
Kim, J., Khan, M., & Park, S. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am404174n · Cited by 139
Dhatariya, K. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.217 · Cited by 119
Fluid balance concepts in medicine: Principles and practice
Roumelioti, M., Glew, R. H., Khitan, Z. J., Rondon‐Berrios, H., Argyropoulos, C., Malhotra, D. K., Raj, D. S., Agaba, E. I., Rohrscheib, M. R., Murata, G. H., et al. (2018) · World Journal of Nephrology · doi:10.5527/wjn.v7.i1.1 · Cited by 139
Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations
Palermo, N. E., Sadhu, A. R., & McDonnell, M. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa360 · Cited by 123
Hamblin, P. S., Wong, R., Ekinci, E. I., Fourlanos, S., Shah, S., Jones, A. R., Hare, M. J. L., Calder, G. L., Epa, D. S., George, E. M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00139 · Cited by 126
Insulin Therapy for the Management of Hyperglycemia in Hospitalized Patients
McDonnell, M. E., & Umpierrez, G. E. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.01.001 · Cited by 117
Self-citationHyperglycemic Hyperosmolar State: An Emerging Pediatric Problem
Rosenbloom, A. L. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.11.057 · Cited by 124
Metadata
- Authors
- Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N.
- Affiliations
- University of Tennessee Health Science Center (US)
- Emory University (US)
- Mayo Clinic (US)
- Corresponding author
- Kitabchi, Abbas E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-07-01
- Volume
- 32
- Issue
- 7
- Pages
- 1335-1343
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2699725
- OpenAlex
- W2162693177
- Cited by
- 2,062
- References
- 118
- Citations by year
- 2026: 121 · 2025: 167 · 2024: 211 · 2023: 173 · 2022: 158 · 2021: 163 · 2020: 167 · 2019: 156 · 2018: 135 · 2017: 121 · 2016: 99 · 2015: 107 · 2014: 82 · 2013: 62 · 2012: 49
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetic ketoacidosis, hyperosmolar hyperglycemic state, precipitating factors, infection, insulin therapy discontinuation, pancreatitis, myocardial infarction, stroke, adult diabetes
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diagnosis, Differential, Humans, Hyperglycemia, Middle Aged, Diabetic Ketoacidosis, Diabetes Complications, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.